SANOFI

Sanofi India Ltd.

NSE: SANOFI

BSE: 500674

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

3,328.40-65.9 (-1.94%)

5 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

80.7 / 100

Value Score

52.2 / 100

Price Momentum Score

10.1 / 100

QVM Score

41.3 / 100

Key Metrics

Market Cap

7665.64

P/E (TTM)

24.74

P/B

10.23

P/S (TTM)

4.32

EV/EBITDA

16.05

CAPE (5Y)

13.55

ROE (TTM)

40.59

ROCE (TTM)

55.13

ROA (TTM)

22.79

Avg 3Y ROE

45.76

Earnings 3Y CAGR

-18.52

Sales 3Y CAGR

-14.11

Sales 5Y CAGR

-9.00

Debt/Equity

0.02

Consensus TP

4487.00

Strong Buy %

33.33

Promoter Holding

60.40

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Sanofi India Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 24.74 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -19.2%

What is P/E Ratio?

Median: 30.62

Value 24.74

0.33296.68

Company's earnings are of high quality

Earnings quality score of 93.6 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

93.6 / 100

Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Weak price momentum

Price Momentum score of 10.1 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

10.1 / 100

Neutral

Moderate dividend yield

The company has a moderate dividend yield of 3.7%

What is Dividend yield?

Financial Snapshot

See detailed analysis

Multi-year trends for Sanofi India Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Sanofi India Ltd. Shareholding Pattern

Quarterly breakdown of Sanofi India Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40
Indian Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign Promoter	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40	60.40
Institutions	28.69	28.61	28.57	28.98	28.72	28.28	28.01	28.27	27.64	27.30	26.53	26.20	26.17	26.38	28.49	28.82	28.99	28.40	28.40	28.35	28.59	28.67	27.85	26.86	26.77	25.55
Mutual Funds / UTI	14.05	13.42	12.92	11.59	9.81	10.13	10.44	10.67	10.19	10.03	9.45	9.40	9.53	9.55	9.97	11.51	11.67	11.59	11.56	11.05	11.26	11.23	10.42	9.46	9.26	9.14
FI/Bank/Insurance	2.44	2.70	3.21	5.82	7.35	7.25	7.21	8.36	8.45	8.56	8.82	9.82	9.93	10.04	11.67	10.96	11.17	10.94	11.05	11.65	11.75	11.82	11.86	11.84	11.86	10.73
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	12.17	12.47	12.42	11.54	11.54	10.87	10.34	9.22	8.99	8.71	8.26	6.99	6.71	6.72	6.80	6.31	6.11	5.81	5.78	5.64	5.58	5.61	5.57	5.55	5.65	5.69
Other Institutions	0.02	0.03	0.02	0.04	0.02	0.02	0.02	0.02	0.00	0.00	0.01	0.00	0.00	0.06	0.04	0.04	0.04	0.07	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Non-Institution	10.92	11.00	11.03	10.62	10.89	11.33	11.59	11.33	11.96	12.30	13.07	13.40	13.43	13.22	11.11	10.78	10.61	11.20	11.20	11.26	11.01	10.94	11.75	12.74	12.83	14.05
Bodies Corporate	3.15	2.77	2.64	2.21	2.27	2.30	2.42	2.42	2.46	2.51	2.51	2.56	2.44	2.65	0.83	0.82	0.89	1.07	1.16	1.08	1.09	1.08	1.07	1.08	0.98	0.91
Others (incl. Retail) No. of shareholders	7.77 34,223	8.23 40,075	8.39 42,026	8.41 42,522	8.62 47,707	9.03 52,916	9.17 50,990	8.91 50,271	9.50 58,642	9.79 63,912	10.56 73,063	10.84 73,948	10.99 76,072	10.57 70,845	10.28 67,936	9.96 62,182	9.72 61,169	10.13 66,978	10.04 65,535	10.18 65,752	9.92 67,569	9.86 66,174	10.68 70,805	11.66 75,254	11.85 75,230	13.14 79,454

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Sanofi India Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Ishares Core Emerging Markets Mauritius Co	17 Oct 2022	sell	₹ 5,743.70	38.86 k	₹ 22.32 cr
Ishares Core Msci Emerging Markets Etf	17 Oct 2022	buy	₹ 5,743.70	38.86 k	₹ 22.32 cr
Ishares India Sc Mauritius Company	17 Oct 2022	sell	₹ 5,743.70	4.49 k	₹ 2.58 cr
Ishares Msci India Small-Cap Etf	17 Oct 2022	buy	₹ 5,743.70	4.49 k	₹ 2.58 cr
Ishares Core Emerging Markets Mauritius Co	11 Oct 2022	sell	₹ 5,887.20	18.91 k	₹ 11.13 cr
Ishares Core Msci Emerging Markets Etf	11 Oct 2022	buy	₹ 5,887.20	18.91 k	₹ 11.13 cr
Ishares India Sc Mauritius Company	11 Oct 2022	sell	₹ 5,887.20	2.18 k	₹ 1.28 cr
Ishares Msci India Small-Cap Etf	11 Oct 2022	buy	₹ 5,887.20	2.18 k	₹ 1.28 cr
Ishares Core Emerging Markets Mauritius Co	19 Sep 2022	sell	₹ 6,056.95	16.20 k	₹ 9.81 cr
Ishares Core Msci Emerging Markets Etf	19 Sep 2022	buy	₹ 6,056.95	16.20 k	₹ 9.81 cr

Corporate Actions

History of Sanofi India Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 48/share
Record date: 22nd Apr 2026Ex-date: 22nd Apr 2026
Announced on: 25th Feb 2026
Dividend₹ 75/share
Record date: 7th Nov 2025Ex-date: 7th Nov 2025
Announced on: 29th Oct 2025
Dividend₹ 117/share
Record date: 25th Apr 2025Ex-date: 25th Apr 2025
Announced on: 28th Feb 2025
Others
Ex-date: 13th Jun 2024Announced on: 10th May 2023
"As part of Demerger each shareholder entitled to receive 1 common share of Sanofi Consumer Healthcare India Limited for every 1 common share held."
Dividend₹ 117/share
Record date: 3rd May 2024Ex-date: 3rd May 2024
Announced on: 23rd Feb 2024

Company Profile

Overview of Sanofi India Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused...

Key personnel

Mr. Haresh Bachubhai Vala

Compliance Officer, Company Secretary

Mr. Bratin Bag

Senior Director - Ethics and Business Integrity, South Asia

Ms. Richa Bakshi

People Excellence Lead

Mr. Arvind Gadekar

Medical Lead - International Pharma SE Asia & India

Ms. Vinifer Gandhi

India Communications and CSR Lead

Mr. Aniket Raje

Regulatory Country Head India

Mr. Linumon Thomas

Digital South East Asia and India Manager

Mr. Rahul BhatnagarD

Non-Executive Independent Chairman of the Board

View all

Incorporated on

02 May 1956

Last Annual

31 Dec 2025

Last Interim

30 Jun 2026

No. of Employees

871

IPO date

28 Nov 1994

Free Float

90,73,872

Website

https://www.sanofi.com/en/india

Phone no.

+912228032000

Address

SANOFI HOUSE, CTS NO. 117-B, L&T BUSINESS PARK, SAKI VIHAR ROAD, POWAI, MUMBAI, , 400072, India

Frequently Asked Questions

What is the current share price of Sanofi India Ltd.?

The current share price of Sanofi India Ltd. is ₹ 3,328.40 as of 5 Aug 2026.

What is the market capitalisation of Sanofi India Ltd.?

The market capitalisation of Sanofi India Ltd. stands at ₹ 7,665.64 Cr.

What is the PE ratio of Sanofi India Ltd.?

The Price-to-Earnings (PE) ratio of Sanofi India Ltd. is 24.74 as of the latest trailing twelve months data.

What is the ROE and ROCE of Sanofi India Ltd.?

Sanofi India Ltd. has a Return on Equity (ROE) of 40.59% and a Return on Capital Employed (ROCE) of 55.13% as per the latest financial reports.

What is the 52-week high and low of Sanofi India Ltd.?

The 52-week high of Sanofi India Ltd. is - and the 52-week low is -.

What is the dividend yield of Sanofi India Ltd.?

The dividend yield of Sanofi India Ltd. is 3.70% based on the current market price.

What is the FII and DII holding in Sanofi India Ltd.?

Foreign Institutional Investors (FII) hold 5.69%, Domestic Institutional Investors (DII) hold 19.87% and retail/public investors hold 13.14% of Sanofi India Ltd. shares.

What sector does Sanofi India Ltd. belong to?

Sanofi India Ltd. operates in the Healthcare sector. 66.67% of analysts have a Buy or Strong Buy rating on Sanofi India Ltd. with a consensus target price of ₹ 4,487.00, implying 34.81% upside from current levels.

What is the beta of Sanofi India Ltd.?

The beta of Sanofi India Ltd. is 0.55, indicating its price volatility relative to the broader market. Over the past 1 year, Sanofi India Ltd. has delivered an absolute return of -42.52%.

What is the RSI of Sanofi India Ltd.?

The 14-day Relative Strength Index (RSI) of Sanofi India Ltd. is 45.30, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Sanofi India Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Sanofi India Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions